New study says Georgia can lead in brain health innovation

 by Maria Saporta February 9, 2026

Georgia can dominate as a hub for brain health and neuroscience.


That’s according to an extensive nine-month-long study conducted by the Georgia Research Alliance (GRA) and Deloitte.

The study examined the academic and research assets that currently exist in Georgia, how the state compares to other states and how Georgia can move forward to leverage its potential.

“This is a once-in-a-generation opportunity to advance brain health,” said Tim Denning, president and CEO of the Georgia Research Alliance (GRA), a public-private entity that includes key civic and business leaders, university presidents and top state officials. “This is a key moment in time — a once-in-a-generation inflexion point.”


The study, funded by a $475,000 grant from the Robert W. Woodruff Foundation, mapped the major assets that already exist in Georgia. Denning presented a summary of the study’s findings at GRA’s Jan. 29 quarterly board meeting, which was held virtually.

The presentation included a map of Georgia’s key assets in brain health and neuroscience. It also showed a wide array of research centers, laboratories, universities and medical facilities that specialize in the field. Read more...

May 13, 2026
Georgia Life Sciences thanks Dr. Marty Makary for his service as Commissioner of the U.S. Food and Drug Administration during a period of significant change across the nation’s health and regulatory agencies.
May 12, 2026
Georgia Life Sciences is pleased to announce Tim Opler as a featured keynote speaker at the 2026 Georgia Life Sciences Summit, taking place August 25-26 at the Sandy Springs Performing Arts Center in Atlanta. A leading voice in biotech investment banking, Tim Opler serves as Managing Director in Stifel’s Global Healthcare Group, where he advises innovative life sciences companies on financing, growth strategy, and market positioning across the healthcare landscape. Tim brings deep insight into the evolving biotech investment environment, emerging industry trends, and the factors shaping the future of life sciences innovation and commercialization. Join us for this timely discussion with one of the industry’s most respected financial leaders as we explore the opportunities and challenges defining the next era of life sciences growth . 
May 5, 2026
New coalition forms to develop a national innovation roadmap to strengthen and extend  America’s global leadership in biotechnology
MORE POSTS